| pubmed-article:11550967 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11550967 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:11550967 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:11550967 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:11550967 | lifeskim:mentions | umls-concept:C1539477 | lld:lifeskim |
| pubmed-article:11550967 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
| pubmed-article:11550967 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:11550967 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:11550967 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11550967 | pubmed:dateCreated | 2001-9-11 | lld:pubmed |
| pubmed-article:11550967 | pubmed:abstractText | To evaluate whether the polymorphism of Fas promoter -670 is associated with susceptibility to systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) and their clinical features. | lld:pubmed |
| pubmed-article:11550967 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11550967 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11550967 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11550967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11550967 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11550967 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11550967 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11550967 | pubmed:issn | 0315-162X | lld:pubmed |
| pubmed-article:11550967 | pubmed:author | pubmed-author:YenL CLC | lld:pubmed |
| pubmed-article:11550967 | pubmed:author | pubmed-author:KimY RYR | lld:pubmed |
| pubmed-article:11550967 | pubmed:author | pubmed-author:SohoKK | lld:pubmed |
| pubmed-article:11550967 | pubmed:author | pubmed-author:SongG GGG | lld:pubmed |
| pubmed-article:11550967 | pubmed:author | pubmed-author:ImJ KJK | lld:pubmed |
| pubmed-article:11550967 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11550967 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:11550967 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11550967 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11550967 | pubmed:pagination | 2008-11 | lld:pubmed |
| pubmed-article:11550967 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:meshHeading | pubmed-meshheading:11550967... | lld:pubmed |
| pubmed-article:11550967 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11550967 | pubmed:articleTitle | Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus. | lld:pubmed |
| pubmed-article:11550967 | pubmed:affiliation | Department of Internal Medicine, College of Medicine, Korea University, Seoul. | lld:pubmed |
| pubmed-article:11550967 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11550967 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11550967 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11550967 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:11550967 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:355 | entrezgene:pubmed | pubmed-article:11550967 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11550967 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11550967 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11550967 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11550967 | lld:pubmed |
